Logo

pancreatic cysts

Biological Dynamics, OHSU Partner to Validate Pancreatic Cancer Early Detection Test

The collaboration will involve testing 520 samples from pancreatic cancer patients and healthy individuals using the exosome-isolating ExoVita Pancreas assay.

Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker

Interpace said that the novel monoclonal antibody, Das-1, will provide additional data regarding pancreatic cancer risk to guide personalized patient management. 

Pancreatic Cancer Sequencing Test From University of Pittsburgh Team Helps Identify Cancerous Cysts
Premium

The seven-gene NGS-based test is available for patients who are found to have pancreatic cysts, and can help physicians decide whether to remove them. 

Interpace Diagnostics Q1 Revenues Up 43 Percent

The diagnostics company said the number of tests accessioned during the quarter grew 60 percent year over year.

Interpace Pancreas Test Reimbursement Code Changed

The new code is expected to streamline the reimbursement process and positively impact the way remittances are received from Medicare and commercial payors.